-

A new “cognitive biotype” of depression, and why it may not respond to medication
Stanford researchers describe a subtype affecting over a quarter of people with depression that resists common antidepressants. We look at what it means and where TMS fits.
-

What Stanford’s SAINT trial means for TMS patients on Vancouver Island
A landmark Stanford trial saw nearly 80% of participants with severe, treatment-resistant depression reach remission using an accelerated form of TMS. Here’s what the research actually shows, and what it means if you’re considering treatment here on the Island.
